rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2000-1-18
|
pubmed:abstractText |
To compare first-line high-dose chemotherapy (HD-CT) with autologous blood stem-cell transplantation to standard-dose chemotherapy (SD-CT) in male patients with advanced germ cell tumors (GCTs), a matched-pair analysis was performed within a homogenous group of patients classified as having either Indiana advanced disease or a poor prognosis according to International Germ Cell Cancer Consensus Group (IGCCCG) criteria.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0732-183X
|
pubmed:author |
pubmed-author:BeyerJJ,
pubmed-author:BokemeyerCC,
pubmed-author:EinhornLL,
pubmed-author:HarstrickAA,
pubmed-author:HartmannJ TJT,
pubmed-author:KanzLL,
pubmed-author:KollmannsbergerCC,
pubmed-author:MeisnerCC,
pubmed-author:MetznerBB,
pubmed-author:NicholsCC,
pubmed-author:SchmollH JHJ
|
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3450-6
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10550141-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10550141-Bleomycin,
pubmed-meshheading:10550141-Cisplatin,
pubmed-meshheading:10550141-Controlled Clinical Trials as Topic,
pubmed-meshheading:10550141-Dose-Response Relationship, Drug,
pubmed-meshheading:10550141-Drug Administration Schedule,
pubmed-meshheading:10550141-Etoposide,
pubmed-meshheading:10550141-Germany,
pubmed-meshheading:10550141-Germinoma,
pubmed-meshheading:10550141-Humans,
pubmed-meshheading:10550141-Ifosfamide,
pubmed-meshheading:10550141-Male,
pubmed-meshheading:10550141-Matched-Pair Analysis,
pubmed-meshheading:10550141-Multivariate Analysis,
pubmed-meshheading:10550141-Neoplasm Metastasis,
pubmed-meshheading:10550141-Prognosis,
pubmed-meshheading:10550141-Survival Rate,
pubmed-meshheading:10550141-United States
|
pubmed:year |
1999
|
pubmed:articleTitle |
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis.
|
pubmed:affiliation |
Department of Hematology/Oncology, University of Tuebingen Medical Center, Tuebingen, Germany.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|